{"id":"NCT01541553","sponsor":"LEO Pharma","briefTitle":"A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp","officialTitle":"A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2013-07","completion":"2013-07","firstPosted":"2012-03-01","resultsPosted":"2014-03-28","lastUpdate":"2025-03-10"},"enrollment":367,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"PROCEDURE","name":"Cryotherapy","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]},{"type":"DRUG","name":"Ingenol metabute","otherNames":["Picato® gel, 0.015%"]}],"arms":[{"label":"PEP005 Gel, 0.015%","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle gel","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to compare the rate of complete clearance of actinic keratosis (AK) using sequential cryotherapy and field treatment with PEP005 Gel compared to cryotherapy alone.","primaryOutcome":{"measure":"Complete Clearance of AKs at Week 11","timeFrame":"11 weeks","effectByArm":[{"arm":"PEP005 Gel, 0.015%","deltaMin":101,"sd":null},{"arm":"Vehicle Gel","deltaMin":80,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":20},"locations":{"siteCount":35,"countries":["United States"]},"refs":{"pmids":["24918567","24509965"],"seeAlso":["https://www.leopharmatrials.com/en"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":167},"commonTop":[]}}